Equity Details
Price & Market Data
Price: $0.09
Daily Change: +$0.00695 / 7.72%
Daily Range: $0.0872 - $0.0945
Market Cap: $14,323,604
Daily Volume: 7,500
Performance Metrics
1 Week: -7.72%
1 Month: -16.87%
3 Months: 4.07%
6 Months: 84.56%
1 Year: 76.70%
YTD: 77.08%
About Inhibitor Therapeutics, Inc. (INTI)
Market summary for Inhibitor Therapeutics, Inc. (INTI). Price: 0.09, daily change: +$0.00695 / 7.72%. Market cap: 14,323,604. Performance YTD, 1-month, 3-month.
Company Details
Employees: 8
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Inhibitor Therapeutics, Inc., a pharmaceutical development company, develops and commercializes therapeutics for patients with certain cancers and non-cancerous proliferation disorders in the United States. It engages in the development of therapies for prostate and lung cancer utilizing itraconazole; and conducted a positive Phase 2b clinical trial of SUBA-Itraconazole for the treatment of basal cell carcinoma nevus syndrome. The company was formerly known as HedgePath Pharmaceuticals, Inc. and changed its name to Inhibitor Therapeutics, Inc. in August 2019. Inhibitor Therapeutics, Inc. was founded in 1992 and is based in Tampa, Florida.